Lung Screening Articles & Analysis
5 articles found
Holding on to this trend of providing highly personalized treatment to patients, Patient-derived Organoid (PDO)-based drug screening has increasingly become a key focus in medical research and drug development. ...
A study conducted under the Lung Cancer Master Protocol (Lung-MAP) found that when treated with a combination of ramuzumab (Cyramza) and Keytruda, Patients with advanced NSCLC whose cancer progressed during prior immunotherapy lived significantly longer than when treated with one of the current standard therapies for this cancer. ...
Xu's lab identified a series of lipid molecules having amide bonds in the tails of the lipid molecules, which make up the LNP with the potential to preferentially deliver mRNA to the lungs of mice, by screening a library of lipid molecules. Further research demonstrated that when lung-targeting LNPs reach the circulation, particular plasma ...
For example, one study found that only 34.5% of Americans living in rural areas had access to a pulmonologist within 10 miles of their home, compared with 97.5% of those living in more urban areas.2 A similar study described the same lack of access to imaging services, finding that 77.8% of patients eligible for lung cancer screening had to drive more than 30 ...
The diagnostic Standard of Care, which ensures CTs are taken for early lung screening, for example, and the amount of development around computer vision AI ensures accuracy. ...